|
Software becomes a key player in
gauging influence of IOL design on PCO development
Sean
Henahan
in San Francisco, US
 |
 |
| Screen
shots from EPCO 2000 highlighting PCO. |
IN a few short years, the EPCO 2000 software program has become
an essential tool for researchers looking at the influence of IOL
edge design and other factors on the development of posterior chamber
opacification (PCO).
German ophthalmic surgeons Manfred Tetz MD and Christophe Nimsgern
MD designed the Windows-based program to provide quantitative analysis
of digitised retro-illumination slit-lamp photographs. The program
allows the user to mark and score opacified areas behind the IOL.
Dr Tetz presented a clinical study during the annual meeting of
the American Society of Cataract and Refractive Surgery in which
the program played an important role. The prospective, randomised,
multicentre trial considered the influence of IOL design on the
development of PCO.
The study compared the incidence of PCO after 12 months in two IOLs
- the single-piece Acrysof SA30AL and the multi-piece MA30BA. Researchers
used the EPCO 2000 program to analyse images acquired from 41 patients
at three, six and 12 months.
At one year, both IOL types showed low levels of PCO growth, with
a mean total PCO score of 10.7%. The single piece IOL had the lower
score at 6.6%, compared with 13.3% for the multi-piece IOL.
“The results suggest that small variations in IOL design can
have an early postoperative impact on PCO development,” Dr
Tetz noted.
The EPCO 2000 analysis failed to uncover a negative effect associated
with the bulky haptic of the one-piece IOL. Such an effect had been
predicted by Japanese researcher Okihiro Nishi MD in a recent publication.
A recent study by Gerd Auffarth MD and colleagues (Ophthalmology
2003; 110:772-780) used the EPCO 2000 programme to compare PCO rates
in a prospective comparison of round and sharp edged IOLs.
They compared outcomes in 121 eyes of 121 patients who received
one of six IOLs - Corneal ACR6, Alcon Acrysof, Allergan AR40, Pharmacia
811 one-piece PMMA lens and Pharmacia 911A silicone IOL. The mean
follow-up period was 14 months.
The researchers used the program to evaluate the morphology of PCO
in the entire optic and 3.0mm central area in each case. The program
revealed that the highest PCO rates occurred with round-edge designs
such as the Corneal ACR6 and the Allergan AR40. PCO rates were significantly
lower for the sharp-edged Alcon and Pharmacia IOLs.
The initial analysis indicated that the Alcon IOLs appeared to have
more PCO when the capsulorhexis rim was not covering the optic edge.
Accordingly, the researchers conducted another study of 53 eyes
of 46 patients who had received Alcon Acrysof IOLs. With nearly
three years of follow-up, the researchers noted a statistically
significant negative correlation between PCO and overlapping of
the rim.
“The sharp edge IOL types (Alcon Acrysof and Pharmacia 911A)
resulted in significantly lower PCO values. We saw no significant
difference between the two sharp edge IOLs. The analysis revealed
that overlapping of capsulorhexis rim and anterior IOL optic surface
by more than 20% resulted in significantly lower PCO values with
the Acrysof IOL,” the researchers note.
The EPCO 2000 system is not the only method available for PCO analysis,
but it may be the most accurate and easy to use, another recent
study suggests (Aslam et al BJO 2002; 86:1181-1186).
Scottish researchers recently compared different systems now in
use for the analysis of PCO.
Analysis of PCO
“Accurate PCO analysis is important for measuring the effect
of treatments that aim to reduce PCO such as intraoperative pharmaceutical
treatments or varying types of surgery. It is also an important
tool for comparing rates of PCO between many available lenses and
the rates of progression with lenses over time,” the researchers
say.
Current systems available for measuring PCO range from simple slit
lamp analysis and subjective grading to more complex computerised
methods of analysis. The optimal system should quantify PCO objectively,
with results that correlate well with changes in vision.
The ideal system should be sensitive enough to pick up small difference
in PCO progression, yet specific enough to compensate for artefacts
such as lens edge.
Visual acuity testing and keeping track of the incidence of YAG
surgery required after cataract surgery are two methods that provide
some idea of postoperative PCO development. However, visual acuity
can be affected by many factors other than PCO. The YAG-surgery
metric is useful, but is subject to many secondary factors such
as economics and practice patterns of specific surgeons.
Subjective
slit lamp grading of PCO, typically on a 0-3 scale, is still widely
used. However, that approach is not quantitative and is subject
to observer bias. It also does not lend itself well to following
progression of PCO over time, the researchers note.
The Scheimpflug system is a far more high-tech approach. The system
utilises the EAS-1000 anterior eye segment analysis system (Nidek),
equipped to perform densitometry and light scattering intensity.
That system has been shown to be efficient and reliable. However,
this approach requires equipment that is not readily available in
many ophthalmology departments.
The EPCO 2000 digital photo acquisition system, in contrast, only
requires equipment that is typically available in any ophthalmology
department. The images can be acquired at a slit lamp equipped with
a digital camera, or scanned from film if necessary. The system
offers rapid access to the images with minimal observer bias. It
has shown itself capable of detecting and following early PCO progression
Merging
A newer feature of the EPCO 2000 system allows merging of two images
of the same capsule, with illumination reflections in opposite halves
of the image. Merging the two images removes any reflective aberrations.
The Scottish team comments that EPCO 2000 has become “the
new standard benchmark system for comparison of PCO rates”.
“After several years of hard work and improvements to the
software itself, it is a very satisfying feeling to see EPCO2000
spreading all over the world. It is now in use throughout Europe,
Asia and the United States. A number of independent research groups
have evaluated the programme and confirmed its reliability,”
Christophe Nimsgern MD, one of the developers of the system, told
EuroTimes.
He noted that an update to the current version of EPCO 2000 is in
the works. The main functions will remain more or less the same,
while the usability and stability of the program will be optimised.
More information is available online at www.epco2000.de.
Manfred Tetz MD
Universitats-Augenklinik Charite, Berlin, Germany
Email: mtetz@charite.de
Top
|